Global Hormonal Contraceptive Market Size By Product (Oral Contraceptives, Skin Patches, Intrauterine Devices), By Harmone (Progestin Only, Combined Hormone Contraceptives), By Geographic Scope And Forecast

Hormonal Contraceptive Market Size And Forecast

Hormonal Contraceptive Market size was valued at USD 16.36 Billion in 2020 and is projected to reach USD 24.21 Billion by 2028, growing at a CAGR of 5.03% from 2021 to 2028.

Increased awareness of birth control methods, as well as increased urbanization and menstruating population worldwide, are expected to drive significant growth in the Hormonal Contraceptive Market. The Global Hormonal Contraceptive Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Hormonal Contraceptive Market Definition

Hormonal Contraceptive are used to prevent pregnancy. There are several types of Hormonal Contraceptive, including birth control pills, hormone-releasing contraceptive coils, the contraceptive skin patch, and the vaginal ring. Hormonal Contraceptive affect women’s hormone levels, and the majority of the work by preventing the release of mature eggs from the ovaries, with some also preventing fertilized eggs from implanting into the uterus. There are two different types of hormonal contraceptive compositionscombined methods that include both estrogen and progesterone, and progestogen-only methods that include only progesterone or one of its synthetic analogs (progestin).

Combined methods suppress ovulation while thickening cervical mucus; while progestogen-only methods reduce ovulation frequency, most of them rely more heavily on changes in cervical mucus. Newer hormonal contraception methods, such as skin patches and vaginal rings, are far less popular, while older methods, such as birth control pills, are the most widely used. Hormonal Contraceptive is also known to alleviate period pain. The disadvantages of hormonal contraception include the possibility of side effects such as mood swings, headaches, and sore breasts, as well as nausea, vaginal infection, and the risk of blood clots

Global Hormonal Contraceptive Market Overview

In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The introduction of new products and increased awareness about reproductive and sexual health in developing countries are expected to drive growth. Furthermore, the increase in population attaining higher education and increasing urbanization is expected to boost the market.

Moreover, rising awareness about pills and devices, the need to prevent unintended pregnancy, and the importance of family planning all contribute to the high demand for contraceptive methods. Additionally, initiatives taken by the respective government to raise awareness about its use and low-cost contraception methods as opposed to permanent contraception methods are fueling the market growth.However, the rise in the use of novel newly arrived contraceptive methods, as well as government participation in promoting safe sex, is limiting the market growth of Hormonal Contraceptive, as hormonal contraceptive do not prevent HIV infection transmission.

Furthermore, the health risks associated with the use of contraception, as well as a lack of social acceptance, have a negative impact on market growth. On the other hand, collaboration and partnership for new product development and Research & development are strategies adopted by some market players, which are likely to provide a large opportunity for the Hormonal Contraceptive Market growth. Further to that, companies’ efforts to develop innovative Hormonal Contraceptive with minimal side effects and improved efficiency are expected to boost Hormonal Contraceptive use in the near future.

Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The “Global Hormonal Contraceptive Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Global Hormonal Contraceptive MarketSegmentation Analysis

The Global Hormonal Contraceptive Market is Segmented on the basis of Product, Hormone, And Geography.

Hormonal Contraceptive Market, By Product

• Oral Contraceptives• Skin Patches• Intrauterine Devices• Hormonal Implants• Others

Based on the Product, The market is classified into Oral Contraceptives, Skin Patches, Intrauterine Devices, Hormonal Implants, and others. Oral Contraceptive Pills accounted for the highest market share and are anticipated to dominate the market during the forecast period. Owing to the ease and simplicity of administration, the wide availability of a wide range of products, the high awareness of pills due to early market entry compared to long-acting devices, and the high efficiency of approximately 99 percent on timely consumption.

Hormonal Contraceptive Market, By Hormone

• Progestin Only• Combined Hormone Contraceptives

Based on Hormone, The market is divided into Progestin Only and Combined Hormone Contraceptives. The most market share was held by the Combined Hormone Contraceptives segment. This is attributed to the wide availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.

Hormonal Contraceptive Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, The Global Hormonal Contraceptive Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the highest market share in the Global Hormonal Contraceptive Market. This can be attributed to high per capita income, the strong presence of key market players, increased sexual health awareness, and a significant number of unintended pregnancies. Whereas, Asia-Pacific is expected to grow at the fastest CAGR during the forecast period due to a large fertile population, the introduction of new female contraception devices, a rise in financing by market players, and strong economic growth.

Key Players

The “Global Hormonal Contraceptive Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc., Mylan N.V., Bayer AG, Agile Therapeutics, Novartis AG, Johnson & Johnson, and The Piramal Group. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations, and Agreements

• In February 2020, TherapeuticsMD, Inc. (NASDAQTXMD), an innovative women’s healthcare company, and Afaxys Pharma, LLC, a pharmaceutical company focused on serving women in the public health system, announced that they have entered into an agreement to expand access to ANNOVERA® (segesterone acetate and ethinyl estradiol vaginal system) in the United States public health sector.

• In October 2018, Allergan plc, a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company announced that the U.S. Food and Drug Administration (FDA) approved Medicines360’s Supplemental New Drug Application (sNDA) to extend the duration of use of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg for the prevention of pregnancy for up to five years.

Mergers and Acquisitions

• In April 2018, Luye Pharma Group Ltd. agreed to acquire the global rights to hormonal contraceptive Apleek from Bayer AG.

Product Launches and Product Expansions

• In September 2020, – Merck Canada Inc., an affiliate of Merck & Co., Inc., known as MSD outside the United States and Canada, announced that NEXPLANON® (etonogestrel implant) 68 mg, a hormonal contraceptive implant, is now available in Canada.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.